Gland Pharma shares jumped to a fresh 52-week high of Rs 2,675.30 on Monday after it signed a large sterile injectables deal with a global pharma major.

The move came after the Hyderabad-based drugmaker, listed on the NSE under the ticker GLAND, disclosed a Manufacturing and Supply Agreement with an unnamed international pharmaceutical company.

Gland Pharma hasn’t named its new partner, citing confidentiality obligations, but describes it as one of the leading players in the global pharma space.

The filing was made under the standard listing disclosure rules Indian companies follow when reporting material agreements to stock exchanges.

Under the deal, Gland Pharma takes on the full job, tech transfer, scale-up, validation, manufacturing, the works.

The scope covers 55 products across cancer and non-cancer treatments, made in formats ranging from vials and ampoules to pre-filled syringes.

Production will run across three of the company’s manufacturing sites, with scope to add more products later.

The numbers sound big, but this is a slow burn. Technology transfer alone is expected to take about two years, and actual revenue from the partnership won’t start until 2029.

Once it’s fully commercialised, Gland Pharma estimates the business could bring in USD 90 to 100 million a year.

Executive Chairman Srinivas Sadu said the tie-up reflects the confidence global pharma companies place in Gland’s manufacturing and regulatory capabilities, and that it strengthens the foundation for the company’s contract manufacturing business going forward.

This isn’t Gland Pharma’s only recent push on the CDMO front. Just days earlier, on 5 August, the company signed a separate agreement with Neuland Laboratories to make sterile active ingredients for injectable depot products, adding about 1,400 kg of annual capacity at its Visakhapatnam plant.

As of 9:45 am, Gland Pharma’s stock was trading at Rs 2,670.20 on the NSE, up 2.66% on the day.

Feeling overwhelmed by the markets? Let Tradz by EquityPandit be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!